Breaking News

ProPharma Group Acquires PI

By Kristin Brooks | January 15, 2014

Establishes global medical information services firm

ProPharma Group, a compliance services company, has acquired Professional Information Ltd. (PI), a provider of medical information services.  The acquisition creates a global medical information (MI) service organization by combining PI with Advanced Response Management (ARM), a subsidiary of ProPharma Group that provides MI services in the U.S., resulting in a large, global organization exclusively focused on MI.
PI, headquartered in Richmond, UK with an office in Melbourne, Australia, handles medical information inquiries, capturing and reporting adverse events, and medical information-writing services throughout Europe, the Middle East, Africa, and Asia-Pacific, supporting more than 22 languages. ARM provides Medical Information services in the U.S., Canada, and Latin America through its Overland Park, KS offices.
Jeff Hargroves, president of ProPharma Group, said,  “ARM and PI have been successfully providing integrated global MI services for two years in a formal partnership. Our current and future clients will benefit from the seamless integration of data compilation and reporting across the globe. The two companies share a common vision of care for colleagues and clients, and we therefore anticipate a very smooth transition into a single corporate entity.”
Following the acquisition, Rachel Lilley, managing director at PI, and Keith Lilley, director of business development, will continue in their current roles.  “We are very excited to work closely with our U.S. counterparts to expand our current high quality, customer-oriented service globally,” said Ms. Lilley.

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity